Overview
Tongli Han practices practicing medicine in Beijing, China.
Their clinical expertise encompasses MELAS Syndrome, Krabbe Disease, Benign Rolandic Epilepsy, and Encephalitis.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tongli Han
Is Tongli Han a top-rated expert for MELAS Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Tongli Han is classified as an Experienced expert for MELAS Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tongli Han participate in research or clinical trials?
Yes. Tongli Han has published 12 articles and abstracts on conditions like MELAS Syndrome. You can view a list of Tongli Han's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anti-NMDA Receptor Encephalitis
- Benign Rolandic EpilepsyHan isExperienced. Learn about Benign Rolandic Epilepsy.
- EncephalitisHan isExperienced. Learn about Encephalitis.
- Krabbe DiseaseHan isExperienced. Learn about Krabbe Disease.
- MELAS SyndromeHan isExperienced. Learn about MELAS Syndrome.